Want to join the conversation?
$MYL announced the U.S. launch of Metformin Hydrochloride Extended-release Tablets, generic version of Watson's Fortamet. $MYL received final approval from the U.S. Food and Drug Administration (FDA) for Abbreviated New Drug Application (ANDA) for this product that is indicated to improve glycemic control in adults with type 2 diabetes mellitus.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?